p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma - Wikidata - wikimedia - TriplyDB

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

http://www.wikidata.org/entity/Q33835838

about

Epidemiology of esophageal cancer Alterations of the TP53 gene in gastric and esophageal carcinogenesis Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction Inhibition of nutlin-resistant HDM2 mutants by stapled peptides Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis.CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis Genetic polymorphism of CCND1 G870A and esophageal cancer susceptibility: A meta-analysis.MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia.Genetic polymorphism of p53, but not GSTP1, is association with susceptibility to esophageal cancer risk - a meta-analysis.MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis.Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population.

P2860

Q24625927-8120C687-4411-428F-A021-24ABE9EB1172 Q26866191-12AAF402-28BF-4ECE-93FA-37A07065E6EF Q27026253-DD2B8453-CC34-4EAE-B05A-DF03BDCA9085 Q27301404-D0D44B82-71D0-4106-9CC1-9096F90EB5A7 Q34763711-58BA256D-4909-40E3-B951-527A714B40A2 Q34848523-2760FC24-E7A3-4244-AC1F-A0AFC7E4C370 Q37344537-8195E3CE-ADCB-4015-A30E-0214C02068E0 Q38221502-23CF5ACD-E4FC-430D-B8C0-0E4F2116B66B Q38291890-6CBA2F1D-16EB-4F0E-B602-25C96B4142D1 Q38396084-683CD260-5A5D-4938-B63A-290FE48B90DA Q40382596-CBEC6927-D03D-49DB-AAE4-94006A00BF89 Q41143120-363007BD-C20E-4D47-88A6-B3F30E4AD81E Q42430422-E27C0AFE-D075-4003-90F4-9A4D94CAA40F Q43209967-689925CD-5DDF-4379-A07D-F3265929F76E Q53226854-2C451336-BBDF-42C9-A679-10A4E2B0135F

P2860

p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma

http://www.wikidata.org/entity/Q33835838

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@ast

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@en

type

label

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@ast

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@en

prefLabel

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@ast

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@en

P1433

Q33835838-EBD63BB7-F4BA-45A9-9BF9-D8FB0A525121

P1476

Q33835838-0DD01D95-8523-420E-80D6-F149F8C16B7D

P2093

Q33835838-0117193E-F97B-42BA-8223-A7AB2AD25F89

Q33835838-24A2195B-A83B-4214-AF86-1B5EE8E189DD

Q33835838-37254CEF-22BD-4208-8B6B-0A00F8F335D4

Q33835838-49DAA8F0-B1DD-42B9-B30C-1CFDEC820F02

Q33835838-5EA5CB87-7410-406D-839E-ECCF357550E2

Q33835838-66573469-017E-4795-9455-6DB147FF580E

Q33835838-A2F1021B-3BF6-4AD3-A859-F9E5212247B4

Q33835838-C9625593-A440-42E7-92EC-AA0D58F195EC

Q33835838-CE851C51-9C26-4DFA-9069-17C5FA75E26A

Q33835838-D5E06332-1A70-4D68-B59C-4552288F3185

P2860

Q33835838-009DEA96-AB20-4C93-ACD7-37D357FE6225

Q33835838-229B6BEE-B55A-40A2-9430-0433D020A741

Q33835838-22CF8EDB-5134-43E8-9533-2126F7872969

Q33835838-2BE9D447-2E9B-4673-8715-D5FDA74F61A2

Q33835838-3614DA10-C95E-4ED3-B161-5B3CA542434A

Q33835838-3EFA1A04-5444-401A-B5B7-932B9C8A5DF1

Q33835838-4118C0E6-23FC-4232-8E4F-B54A284C6CE7

Q33835838-442EB8D0-131A-4EAA-9A7C-9D1551E5F662

Q33835838-44B49984-807D-460B-B72D-6FC9A8755B6A

Q33835838-66A7D2A6-1471-47C6-8CE6-F218872A7203

P304

Q33835838-33BAE47D-C50A-40DB-BEE3-754B163DA352

P31

Q33835838-C6B504D0-DFC9-4C2A-AEBC-0EAC911C9EEB

P356

Q33835838-0BF37E23-8397-4337-85CD-732C76BAA410

P433

Q33835838-FBCDEC55-10B4-4A24-A031-9714BA0B165E

P478

Q33835838-474933AA-419E-4F10-9BEB-3FD2637481E4

P50

Q33835838-F7B4AD0E-3316-4394-A4ED-DDA728281713

P577

Q33835838-EC968544-92DB-45F9-B62B-4099C1C4B5E1

P5875

Q33835838-B4904F08-3155-4C47-BF3B-8283BAB807D7

P698

Q33835838-E50B4FE5-92F6-48F0-910C-2A2C28C2A827

P921

Q33835838-31586798-D079-4D69-A268-27E3D90673DC

P932

Q33835838-C2B10F2D-C6F0-4A66-B9C9-7D0A19D11F80

P356

J.1442-2050.2009.00960.X

P1433

Diseases of the Esophagus

P1476

p53 Arg72Pro, MDM2 T309G and C ...... y to esophageal adenocarcinoma

@en

P2093

C Ma

http://www.w3.org/2001/XMLSchema#string

D C Christiani

http://www.w3.org/2001/XMLSchema#string

D W Cescon

http://www.w3.org/2001/XMLSchema#string

J C Wain

http://www.w3.org/2001/XMLSchema#string

K Asomaning

http://www.w3.org/2001/XMLSchema#string

L Su

http://www.w3.org/2001/XMLSchema#string

M H Kulke

http://www.w3.org/2001/XMLSchema#string

R S Heist

http://www.w3.org/2001/XMLSchema#string

R Zhai

http://www.w3.org/2001/XMLSchema#string

T J Lynch

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin D1: polymorphism, aberrant splicing and cancer risk

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect.

Polymorphisms in the p53 pathway.

Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma

A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.

Genetic polymorphisms and esophageal cancer risk.

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome

Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.

Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.

P304

36-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1442-2050.2009.00960.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24215904

http://www.w3.org/2001/XMLSchema#string

P698

19302219

http://www.w3.org/2001/XMLSchema#string

P921

P932

2866140

http://www.w3.org/2001/XMLSchema#string